Drug Type Small molecule drug |
Synonyms- |
Target |
Action- |
Mechanism HIF-2α inhibitors(Endothelial PAS domain-containing protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arthritis | Discovery | - | 04 Apr 2024 | |
| Endocrinology and Metabolic Disease | Discovery | - | 04 Apr 2024 | |
| Enteritis | Discovery | - | 04 Apr 2024 | |
| Immune System Diseases | Discovery | - | 04 Apr 2024 | |
| Inflammation | Discovery | - | 04 Apr 2024 | |
| Neoplasms | Discovery | - | 04 Apr 2024 | |
| Nephritis | Discovery | - | 04 Apr 2024 | |
| Pneumonia | Discovery | - | 04 Apr 2024 | |
| Surgical Wound Infection | Discovery | - | 04 Apr 2024 |





